Condition | Cancer

Alliance A011502

  • IRB Number: Alliance A011502
  • Contact Name: Rachel O'Loughlin, RN
  • Status: Enrolling
  • Phone: (585) 747-4555
  • Lead Researcher: Peter Bushunow, MD

Description

A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial